The effect of growth hormone replacement therapy on adrenal androgen secretion in adult onset hypopituitarism

Clinical Endocrinology

Volumn 58, Issue 5, 2003, Pages 601-611

  Isidori, A M ^a   Kaltsas, G A ^a   Perry, L ^a   Burrin, J M ^a   Besser, G M ^a   Monson, J P ^a,b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; GROWTH HORMONE; HYDROCORTISONE; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ANDROGEN RELEASE; ANDROGEN SYNTHESIS; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HORMONAL REGULATION; HORMONAL THERAPY; HORMONE ACTION; HORMONE INHIBITION; HORMONE SENSITIVITY; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOGLYCEMIA; HYPOPITUITARISM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MALE; PATIENT CODING; PRIORITY JOURNAL; PROVOCATION TEST; STATISTICAL ANALYSIS; TESTOSTERONE BLOOD LEVEL;

ADRENAL GLANDS; ADRENOCORTICOTROPIC HORMONE; ADULT; ANDROGENS; ANDROSTENEDIONE; ANTI-INFLAMMATORY AGENTS; BODY WEIGHT; CARRIER PROTEINS; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; GONADAL STEROID HORMONES; GROWTH SUBSTANCES; HORMONE REPLACEMENT THERAPY; HUMANS; HYDROCORTISONE; HYPOPITUITARISM; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; RADIOIMMUNOASSAY; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 0038332161     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2003.01759.x     Document Type: Article

References (42)

1. Aimaretti, G., Baffoni, C., Ambrozio, M.R., Maccario, M., Corneli, G., Bellone, S., Gasperi, M., degli Uberti, E.C. & Ghigo, E. (2000) DHEA-S levels in hypopituitaric patients with severe GH deficiency are strongly reduced across lifespan. Comparison with IGF-I levels before and during rhGH replacement. Journal of Endocrinological Investigation, 23, 5-11
2. Albertson, B.D., Hobson, W.C., Burnett, B.S., Turner, P.T., Clark, R.V., Schiebinger, R.J., Loriaux, D.L. & Cutler, G.B. Jr (1984) Dissociation of cortisol and adrenal androgen secretion in the hypophysectomized, adrenocorticotropin-replaced chimpanzee. Journal of Clinical Endocrinology and Metabolism, 59, 13-18.
3. l'Allemand, D. & Biason-Lauber, A. (2000) Intra-adrenal regulation of androgen synthesis. European Journal of Clinical Investigation, 30, 28-33.
4. Arlt, W., Callies, F. & Allolio, B. (2000) DHEA replacement in women with adrenal insufficiency: pharmacokinetics, bioconversion and clinical effects on well-being, sexuality and cognition. Endocrine Research, 26, 505-511.
5. Balducci, R., Toscano, V., Larizza, D., Mangiantini, A., Galasso, C., Municchi, G., Di Rito, A., Picone, S. & Boscherini, B. (1998) Effects of long-term growth hormone therapy on adrenal steroidogenesis in Turner's syndrome. Hormone Research, 49, 210-215.
6. Cohen, H.N., Wallace, A.M., Beastall, G.H., Fogelman, I. & Thomson, J.A. (1981) Clinical value of adrenal androgen measurement in the diagnosis of delayed puberty. Lancet, 1, 689-692.
7. Cutler, G.B. Jr, Davis, S.E., Johnsonbaugh, R.E. & Loriaux, D.L. (1979) Dissociation of cortisol and adrenal androgen secretion in patients with secondary adrenal insufficiency. Journal of Clinical Endocrinology and Metabolism, 49, 604-609.
8. Drake, W.M., Coyte, D., Camacho-Hubner, C., Jivanji, N.M., Kaltsas, G., Wood, D.F., Trainer, P.J., Grossman, A.B., Besser, G.M. & Monson, J.P. (1998) Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults. Journal of Clinical Endocrinology and Metabolism, 83, 3913-3919.
9. Gelding, S.V., Taylor, N.F., Wood, P.J., Noonan, K., Weaver, J.U., Wood, D.F. & Monson, J.P. (1998) The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11β-hydroxysteroid dehydrogenase activity. Clinical Endocrinology, 48, 153-162.
10. Ibanez, L., Dimartino-Nardi, J., Potau, N. & Saenger, P. (2000) Premature adrenarche: normal variant or forerunner of adult disease? Endocrine Reviews, 21, 671-696.
11. Ilondo, M.M., Vanderschueren-Lodeweyckx, M., Vlietinck, R., Pizarro, M., Malvaux, P., Eggermont, E. & Eeckels, R. (1982a) Plasma androgens in children and adolescents. Part I: control subjects. Hormone Research, 16, 61-77.
12. Ilondo, M.M., Vanderschueren-Lodeweyckx, M., Vlietinck, R., Pizarro, M., Malvaux, P., Eggermont, E. & Eeckels, R. (1982b) Plasma androgens in children and adolescents. Part II: A longitudinal study in patients with hypopituitarism. Hormone Research, 16, 78-95.
13. Jamieson, A., Wallace, A.M., Andrew, R., Nunez, B.S., Walker, B.R., Fraser, R., White, P.C. & Connell, J.M. (1999) Apparent cortisone reductase deficiency: a functional defect in 11β-hydroxysteroid dehydrogenase type 1. Journal of Clinical Endocrinology and Metabolism, 84, 3570-3574.
14. Juul, A., Andersson, A.M., Pedersen, S.A., Jorgensen, J.O., Christiansen, J.S., Groome, N.P. & Skakkebaek, N.E. (1998) Effects of growth hormone replacement therapy on IGF-related parameters and on the pituitary-gonadal axis in GH-deficient males. A double-blind, placebo-controlled crossover study. Hormone Research, 49, 269-278.
15. Lew, L.Q., Sklar, C.A., Yoon, D.J. & David, R. (1988) Adrenal androgens in children with short stature. Hormone Research, 29, 151-155.
16. Lim, N.Y. & Dingman, J.F. (1964) Androgenic adrenal hyperfunction in acromegaly. New England Journal of Medicine, 271, 1189-1194.
17. Lin, C.J., Mendonca, B.B., Lucon, A.M., Guazzelli, I.C., Nicolau, W. & Villares, S.M. (1997) Growth hormone receptor messenger ribonucleic acid in normal and pathologic human adrenocortical tissues: an analysis by quantitative polymerase chain reaction technique. Journal of Clinical Endocrinology and Metabolism, 82, 2671-2676.
18. Miller, K.K., Sesmilo, G., Schiller, A., Schoenfeld, D., Burton, S. & Klibanski, A. (2001) Androgen deficiency in women with hypopituitarism. Journal of Clinical Endocrinology and Metabolism, 86, 561-567.
19. Monson, J.P. (1998) Growth hormone and cortisol metabolism. Clinical Endocrinology, 49, 281-282.
20. Moore, J.S., Monson, J.P., Kaltsas, G., Putignano, P., Wood, P.J., Sheppard, M.C., Besser, G.M., Taylor, N.F. & Stewart, P.M. (1999) Modulation of 11β-hydroxysteroid dehydrogenase isozymes by growth hormone and insulin-like growth factor: in vivo and in vitro studies. Journal of Clinical Endocrinology and Metabolism, 84, 4172-4177.
21. Morales, A.J., Haubrich, R.H., Hwang, J.Y., Asakura, H. & Yen, S.S. (1998) The effect of 6 months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clinical Endocrinology, 49, 421-432.
22. Morales, A.J., Nolan, J.J., Nelson, J.C. & Yen, S.S. (1994) Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age [published erratum appears in J Clin Endocrinol Metab 1995; 80: 2799]. Journal of Clinical Endocrinology and Metabolism, 78, 1360-1367.
23. Morrell, D.J., Dadi, H., More, J. et al. (1989) A monoclonal antibody to human insulin-like growth factor-I: characterisation, use in radioimmunoassay and effect on the biological activities of the growth factor. Journal of Molecular Endocrinology, 2, 201-206.
24. Palermo, M., Shackleton, C.H., Mantero, F. & Stewart, P.M. (1996) Urinary free cortisone and the assessment of 11β-hydroxysteroid dehydrogenase activity in man. Clinical Endocrinology, 45, 605-611.
25. Parker, L.N. & Odell, W.D. (1980) Control of adrenal androgen secretion. Endocrine Reviews, 1, 392-410.
26. Penning, T.M. (1997) Molecular endocrinology of hydroxysteroid dehydrogenases. Endocrine Reviews, 18, 281-305.
27. Phillipov, G., Palermo, M. & Shackleton, C.H. (1996) Apparent cortisone reductase deficiency: a unique form of hypercortisolism. Journal of Clinical Endocrinology and Metabolism, 81, 3855-3860.
28. Raven, P.W. & Taylor, N.F. (1996) Sex differences in the human metabolism of cortisol. Endocrine Research, 22, 751-755.
29. Rodin, A., Thakkar, H., Taylor, N. & Clayton, R. (1994) Hyperandrogenism in polycystic ovary syndrome. Evidence of dysregulation of 11β-hydroxysteroid dehydrogenase [see comments]. New England Journal of Medicine, 330, 460-465.
30. Rodriguez-Arnao, J., Perry, L., Besser, G.M. & Ross, R.J. (1996) Growth hormone treatment in hypopituitary GH-deficient adults reduces circulating cortisol levels during hydrocortisone replacement therapy. Clinical Endocrinology, 45, 33-37.
31. Rossi, E., Merola, B., Longobardi, S., Esposito, V., Tommaselli, A.P., Colao, A. & Lombardi, G. (1995) Acute and chronic effects of human recombinant GH (hrGH) on adrenal steroidogenesis in children affected with isolated GH deficiency (IGHD). Journal of Clinical Endocrinology and Metabolism, 80, 2251-2254.
32. Rudd, B.T., Rayner, P.H., Bassett, R.M. & Williams, J.W. (1980) Serum dehydroepiandrosterone (DHA) and sulphate (DHAS) after acute growth hormone therapy. Acta Paediatrica Scandinavica, 69, 287-292.
33. Sklar, C.A. & Ulstrom, R.A. (1984) Effect of human growth hormone on adrenal androgens in children with growth hormone deficiency. Hormone Research, 20, 166-171.
34. Smith, R.G., Pong, S.S., Hickey, G., Jacks, T., Cheng, K., Leonard, R., Cohen, C.J., Arena, J.P., Chang, C.H., Drisko, J., Wyvratt, M., Fisher, M., Nargund, R. & Patchett, A. (1996) Modulation of pulsatile GH release through a novel receptor in hypothalamus and pituitary gland. Recent Progress in Hormone Research, 51, 261-285.
35. Span, J.P., Pieters, G.F., Sweep, C.G., Hermus, A.R. & Smals, A.G. (2000) Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: role of sex hormone replacement. Journal of Clinical Endocrinology and Metabolism, 85, 1121-1125.
36. Stewart, P.M., Shackleton, C.H., Beastall, G.H. & Edwards, C.R. (1990) 5α-reductase activity in polycystic ovary syndrome. Lancet, 335, 431-433.
37. Trainer, P.J., Besser, G.M. & St. Bartholomew's, H. (1995) The Bart's Endocrine Protocols. Churchill Livingstone, Edinburgh.
38. Villareal, D.T., Holloszy, J.O. & Kohrt, W.M. (2000) Effects of DHEA replacement on bone mineral density and body composition in elderly women and men. Clinical Endocrinology, 53, 561-568.
39. Walker, B.R., Andrew, R., Macleod, K.M. & Padfield, P.L. (1998) Growth hormone replacement inhibits renal and hepatic 11 beta-hydroxysteroid dehydrogenases in ACTH-deficient patients. Clinical Endocrinology, 49, 257-263.
40. Weaver, J.U., Thaventhiran, L., Noonan, K., Burrin, J.M., Taylor, N.F., Norman, M.R. & Monson, J.P. (1994) The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults. Clinical Endocrinology, 41, 639-648.
41. Young, J., Couzinet, B., Nahoul, K., Brailly, S., Chanson, P., Baulieu, E.E. & Schaison, G. (1997) Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans. Journal of Clinical Endocrinology and Metabolism, 82, 2578-2585.
42. Zogopoulos, G., Albrecht, S., Pietsch, T., Alpert, L., von Schweinitz, D., Lefebvre, Y. & Goodyer, C.G. (1996) Fetal- and tumor-specific regulation of growth hormone receptor messenger RNA expression in human liver. Cancer Research, 56, 2949-2953.